Similar to EBV-positive aggressive NK-cell leukemia/lymphoma, our patients presented with constitutional symptoms and hepatosplenomegaly, and followed a highly aggressive clinical course.

Stadlmann S, Fend F, Moser P, et al. Epstein–Barr virus-associated extranodal NK/T-cell lymphoma, nasal type of the hypopharynx, in a renal allograft recipient: case report and review of literature.

Epstein–Barr Virus & NK-cell Lymphomas An almost invariable observation in NK-cell lymphomas obtained from Asian, European and South American patients is the presence of Epstein ...

Chronic active Epstein-Barr virus infection (CAEBV) is an inflammatory disorder with potential for tumor development. Here, unusual phosphorylation was observed on STAT3 in EBV-infected T- or NK ...

Relapse of natural killer (NK) cell–T-cell neoplasms in the leukemic phase in a patient who has received l-asparaginase–based combination therapy and undergone allogeneic hematopoietic-cell ...

Aggressive natural killer cell leukemia (ANKL) is a rare and aggressive type of blood cancer that affects white blood cells called “natural killer (NK) cells”. In ANKL, the NK cells are ...

B) CD16-158V electroporated or non-electroporated expanded NK cells were cocultured with EBV-transformed B cell lymphoma cells (CD20+ 721.221 EBV-LCL cells) in the presence or absence of rituximab ...

Indapta Therapeutics to Highlight its g-NK Cell Platform for the ... namely their ability to kill HLA-E expressing autoreactive T and B cells as well as address the Epstein Barr Virus ...

The Epstein–Barr virus (EBV) was discovered 36 years ago by electron microscopy of cells cultured from Burkitt's lymphoma tissue by Epstein, Achong, and Barr.1 Four years later, in 1968, EBV was ...

Natural killer cells (also known as NK cells, K cells, and killer cells) are a type of lymphocyte (a white blood cell) and a component of innate immune system. NK cells play a major role in the ...

Granulocyte colony-stimulating factor to be started on day 6. Cycles to be repeated every 28 days. SMILE: Dexamethasone, methotrexate, ifosfamide, L-asparaginase and etoposide. Stage I/II Involved ...